Genelux (GNLX) Cash from Financing Activities (2022 - 2026)

Genelux (GNLX) recorded quarterly Cash from Financing Activities of $18.5 million in Q1 2026, up 6616.67% quarter-over-quarter from $276000.0 in Q4 2025, and up 93.77% on a YoY basis from $9.6 million in Q1 2025.

Genelux (GNLX) Cash from Financing Activities (2022 - 2026) Analysis & Trends

Genelux's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $18.5 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 93.77% year-over-year to $18.5 million; the TTM figure through Mar 2026 stood at $18.9 million (down 49.54% YoY), while the FY2025 annual figure was $9.9 million, down 65.29% from the prior year.
  • Cash from Financing Activities was $18.5 million for Q1 2026 at Genelux, up from $276000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $27.7 million in Q2 2024 to a low of -$130000.0 in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $7.8 million across 5 years, with a median of $688000.0 in 2024.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 11361.54% in 2023, then plunged 99.81% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $545000.0 in 2022, then retreated by 26.42% to $401000.0 in 2023, then sank by 77.31% to $91000.0 in 2024, then surged by 203.3% to $276000.0 in 2025, then soared by 6616.67% to $18.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at $18.5 million (Q1 2026), $276000.0 (Q4 2025), and $52000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Genelux 129.36 Mn 129.36 Mn - 18.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.54 Mn
Mar 31, 2026 18.54 Mn
Dec 31, 2025 276,000.00
Dec 31, 2025 276,000.00
Jun 30, 2025 52,000.00
Jun 30, 2025 52,000.00
Mar 31, 2025 9.57 Mn
Mar 31, 2025 9.57 Mn
Dec 31, 2024 91,000.00
Dec 31, 2024 91,000.00
Jun 30, 2024 27.73 Mn
Jun 30, 2024 27.73 Mn
Mar 31, 2024 688,000.00
Mar 31, 2024 688,000.00
Dec 31, 2023 401,000.00
Dec 31, 2023 401,000.00
Sep 30, 2023 6.36 Mn
Sep 30, 2023 6.36 Mn
Jun 30, 2023 22.62 Mn
Jun 30, 2023 22.62 Mn